Despite tremendous scientific innovation and the availability of advanced treatments, ageist systems, attitudes, and beliefs continue to place countless lives at unnecessary risk by preventing timely access to care and treatment. The paper shares evidence of ageism’s impact on health outcomes and system costs and outlines concrete steps for stakeholders to take in the fight…

On June 6, 2024, The Global Coalition on Aging (GCOA) Alliance for Health Innovation convened a roundtable discussion of cross-sectoral experts representing patients, caregivers, academia, biopharmaceutical innovators, and business communities to discuss Prescription Drug Affordability Boards (PDABs), Upper Payment Limits (UPLs), and the risk they pose to the innovation that is needed to safeguard healthy…

At the World Summit on the Information Society, May 30, 2024, GCOA hosted a panel discussion on the global health crisis that is AMR and how technology can, should and will have an impact through diagnostics, surveillance, and innovative developments.  AMR will be responsible for 10 million deaths annually by 2050 – on track to…

Respiratory infections like influenza, RSV (respiratory syncytial virus), and now COVID-19, among others, place a substantial and growing burden on health systems. Among these three infections—responsible for the so called “tripledemic”—RSV is the least recognized. There is low awareness of RSV among healthcare professionals and the general public and little understanding of the disease burden…

On September 27, 2023, The Global Coalition on Aging (GCOA) Alliance for Health Innovation and The American Federation for Aging Research (AFAR) convened for a roundtable discussion on cancer, innovation, and healthy aging. Experts on cancer treatment, health policy, aging, and patient voices explored the value of biomedical innovation, and the importance of both the…